$CNTB Balance Sheet | Understand Stock

$CNTB

$0.85 +$0.00 (0.33%) Close

$CNTB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021
Property, plant and equipment
Right-of-use assets
Intangible assets
Financial assets at fair value through other comprehensive income
Other non-current assets
Total non-current assets
Other receivables and prepayments
Cash and cash equivalents
Total current assets
Total assets
Lease liabilities
Deferred income
Total non-current liabilities
Trade payables
Other payables and accruals
Contract liabilities
Total current liabilities
Total liabilities
Net assets
Share capital
Share premium
Treasury shares
Share-based compensation reserves
Other reserves
Accumulated losses
ASSETS
Current assets:
Cash and cash equivalents
Short-term investments
Accounts receivable, net
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Right-of-use lease assets, net
Intangible assets, net
Other assets
Total assets
LIABILITIES AND SHAREHOLDERS' EQUITY
Current liabilities:
Accounts payable
Accrued liabilities
Contract liabilities
Current lease liabilities
Total current liabilities
Non-current lease liabilities
Other non-current liabilities
Total liabilities
Shareholders' equity:
Preferred shares, $0.000174 par value: 40,000,000 shares authorized; no shares issued or outstanding at December 31, 2025 and 2024
Ordinary shares, $0.000174 par value; 400,000,000 shares authorized; 62,974,309 and 56,442,308 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Accumulated other comprehensive loss
Treasury shares
Accumulated deficit
Total shareholders' equity
Total liabilities and shareholders' equity

Comments